Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glatiramer acetate effects on fatigue and MRI measures in multiple sclerosis
2011-000150-31Phase 4Active
- Sponsor
- Fondazione Don Carlo Gnocchi
- Start
- Dec 2011
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 4, open-label trial of glatiramer acetate in multiple sclerosis (MS) (2 arms), sponsored by Fondazione Don Carlo Gnocchi. Started Dec 2011; status: active.
02
Drugs
glatiramer acetate
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on 2011-000150-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-000150-31.